PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Urology, Chaim Sheba Medical Center, Ramat Gan, Israel, The Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel; The Dr. Pinchas Borenstein Talpiot Medical Leadership Program 2013, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. Electronic address: Barak.rosenzweig@sheba.health.gov.il.\', \'UCL Division of Surgery and Interventional Science, Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.\', \'Department of Urology, Chaim Sheba Medical Center, Ramat Gan, Israel, The Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.\', \'Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.\', \'Division of Urology, University of Toronto, Toronto, Ontario, Canada.\', \'Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.\', \'Clinic E Cavell and University of Brussels, Brussels, Belgium.\', \'Department of Urology, University Hospital of Mainz, Mainz, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1078-1439(20)30437-310.1016/j.urolonc.2020.09.015
?:hasPublicationType
?:journal
  • Urologic oncology
is ?:pmid of
?:pmid
?:pmid
  • 33036903
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all